(Q84594220)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Omer Kilic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yildiz Camcioglu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Haluk Cokugras

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Nil Arisoy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Necla Akcakaya

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

26 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

2675-2679

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21789614%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00296-011-2030-8

8 February 2020

exact match

0 references

cites work

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

1 reference

12 December 2020

Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy

1 reference

12 December 2020

Granulomatous infections due to tumor necrosis factor blockade: correction

1 reference

12 December 2020

Granulomatous infectious diseases associated with tumor necrosis factor antagonists

1 reference

12 December 2020

Purified protein derivative response in juvenile idiopathic arthritis

1 reference

12 December 2020

Tuberculosis associated with therapy against tumor necrosis factor alpha

1 reference

12 December 2020

Juvenile idiopathic arthritis

1 reference

12 December 2020

BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment

1 reference

12 December 2020

The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TnFalpha therapy

1 reference

12 December 2020

Physiology of cytokine pathways in rheumatoid arthritis

1 reference

12 December 2020

Infections associated with tumor necrosis factor-alpha antagonists

1 reference

12 December 2020

New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals

1 reference

12 December 2020

TNF-alpha antagonist therapy modify the tuberculin skin test response.

1 reference

12 December 2020

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

1 reference

12 December 2020

Follow-up results of 702 patients receiving tumor necrosis factor-α antagonists and evaluation of risk of tuberculosis

1 reference

12 December 2020

Mantoux Test as a model for a secondary immune response in humans

1 reference

12 December 2020

Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan.

1 reference

12 December 2020

Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy

1 reference

12 December 2020

Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity

1 reference

12 December 2020

French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers

1 reference

12 December 2020

Preventing tuberculosis in children receiving anti-TNF treatment

1 reference

12 December 2020

Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection.

1 reference

12 December 2020

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

12 December 2020